Hybrid Options for Treating Cardiac Disease

Seminars in Thoracic and Cardiovascular Surgery

Volumn 23, Issue 4, 2011, Pages 274-280

  Umakanthan, Ramanan ^a   Leacche, Marzia ^a   Zhao, David X ^a   Gallion, Anna H ^a   Mishra, Prabodh C ^a   Byrne, John G ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac surgery; Hybrid therapy; Interventional cardiology

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE;

ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED SURGERY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENDOSCOPIC SURGERY; EVENT FREE SURVIVAL; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; INTERNAL MAMMARY ARTERY; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOADING DRUG DOSE; MINIMALLY INVASIVE CARDIAC SURGERY; OPERATION DURATION; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PROCESS DEVELOPMENT; PUBLIC-PRIVATE PARTNERSHIP; STENT THROMBOSIS; STERNOTOMY; TREATMENT INDICATION; TREATMENT PLANNING;

CARDIAC SURGICAL PROCEDURES; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HEART CATHETERIZATION; HEART DISEASES; HUMANS; INTERDISCIPLINARY COMMUNICATION; PATIENT CARE TEAM; TREATMENT OUTCOME;

EID: 84858724608     PISSN: 10430679     EISSN: 15329488     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2011.12.002     Document Type: Article

References (45)

1. Angelini G.D., Wilde P., Salerno T.A., et al. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularization. Lancet 1996, 347:757-758.
2. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996, 335:217-225. The Bypass Angioplasty Revascularization Investigation (BARI) investigators.
3. Serruys P.W., Morice M.C., Kappetein A.P., et al. SYNTAX investigators: Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009, 360:961-972.
4. Tatoulis J., Buxton B.F., Fuller J.A. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg 2004, 77:93-101.
5. BARI trial: The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007, 49:1600-1606. The Bypass Angioplasty Revascularization Investigation (BARI) investigators.
6. Patel M.R., Dehmer G.J., Hirshfeld J.W., et al. Appropriateness criteria for coronary revascularization: A report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology-Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. Circulation 2009, 119:1330-1352.
7. Lytle B.W., Loop F.D., Taylor P.C., et al. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg 1993, 105:605-614.
8. Alexander J.H., Hafley G., Harrington R.A., et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV-A randomized controlled trial. JAMA 2005, 294:2446-2454.
9. Puskas J.D., Williams W.H., Mahoney E.M., et al. Off-pump vs conventional coronary artery bypass grafting: Early and 1-year graft patency, cost, and quality-of-life outcomes: A randomized trial. JAMA 2004, 291:1841-1849.
10. Balacumaraswami L., Taggart D.P. Intraoperative imaging techniques to assess coronary artery bypass graft patency. Ann Thorac Surg 2007, 83:2251-2257.
11. Grube E., Silber S., Hauptmann K.E., et al. TAXUS I: Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003, 107:38-42.
12. Mauri L., Orav E.J., Kuntz R.E. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 2005, 111:3435-3442.
13. Tanabe K., Serruys P.W., Grube E., et al. TAXUS III trial: In-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003, 107:559-564.
14. Lloyd C.T., Calafiore A.M., Wilde P., et al. Integrated left anterior small thoracotomy and angioplasty for coronary artery revascularization. Ann Thorac Surg 1999, 68:908-912.
15. Isomura T., Suma H., Horii T., et al. Minimally invasive coronary artery revascularization: Off-pump bypass grafting and the hybrid procedure. Ann Thorac Surg 2000, 70:2017-2022.
16. de Cannière D., Jansens J.L., Goldschmidt-Clermont P., et al. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: Two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting. Am Heart J 2001, 142:563-570.
17. Presbitero P., Nicolini F., Maiello L., et al. "Hybrid" percutaneous and surgical coronary revascularization: Selection criteria from a single-center experience. Ital Heart J 2001, 2:363-368.
18. Cisowski M., Morawski W., Drzewiecki J., et al. Integrated minimally invasive direct coronary artery bypass grafting and angioplasty for coronary artery revascularization. Eur J Cardiothorac Surg 2002, 22:261-265.
19. Stahl K.D., Boyd W.D., Vassiliades T.A., et al. Hybrid robotic coronary artery surgery and angioplasty in multivessel coronary artery disease. Ann Thorac Surg 2002, 74:S1358-S1362.
20. Angelini G.D., Taylor F.C., Reeves B.C., et al. Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): A pooled analysis of two randomised controlled trials. Lancet 2002, 359:1194-1199.
21. Lewis B.S., Porat E., Halon D.A., et al. Same-day combined coronary angioplasty and minimally invasive coronary surgery. Am J Cardiol 1999, 8484:1246-1247.
22. Wittwer T., Cremer J., Klima U., et al. Myocardial "hybrid" revascularization: Intermediate results of an alternative approach to multivessel coronary artery disease. J Thorac Cardiovasc Surg 1999, 118:766-767.
23. Riess F.C., Bader R., Kremer P., et al. Coronary hybrid revascularization from January 1997 to January 2001: A clinical follow-up. Ann Thorac Surg 2002, 73:1849-1855.
24. Zenati M., Cohen H.A., Griffith B.P. Alternative approach to multivessel coronary disease with integrated coronary revascularization. J Thorac Cardiovasc Surg 1999, 117:439-446.
25. Us M.H., Basaran M., Yilmaz M., et al. Hybrid coronary revascularization in high-risk patients. Tex Heart Inst J 2006, 33:458-462.
26. Gilard M., Bezon E., Cornily J.C., et al. Same-day combined percutaneous coronary intervention and coronary artery surgery. Cardiology 2007, 108:363-367.
27. Kon Z.N., Brown E.N., Tran R., et al. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. J Thorac Cardiovasc Surg 2008, 135:367-375.
28. Lee M.S., Wilentz J.R., Makkar R.R., et al. Hybrid revascularization using percutaneous coronary intervention and robotically assisted minimally invasive direct coronary artery bypass surgery. J Invasive Cardiol 2004, 16:419-425.
29. Davidavicius G., Van Praet F., Mansour S., et al. Hybrid revascularization strategy: A pilot study on the association of robotically enhanced minimally invasive direct coronary artery bypass surgery and fractional-flow-reserve-guided percutaneous coronary intervention. Circulation 2005, 112:I317-I322.
30. Kiaii B., McClure R.S., Kostuk W.J., et al. Concurrent robotic hybrid revascularization using an enhanced operative suite. Chest 2005, 128:4046-4048.
31. Katz M.R., Van Praet F., de Canniere D., et al. Integrated coronary revascularization: Percutaneous coronary intervention plus robotic totally endoscopic coronary artery bypass. Circulation 2006, 114:I473-I476.
32. Vassiliades T.A., Douglas J.S., Morris D.C., et al. Integrated coronary revascularization with drug-eluting stents: Immediate and seven-month outcome. J Thorac Cardiovasc Surg 2006, 131:956-962.
33. Bonatti J., Schachner T., Bonaros N., et al. Simultaneous hybrid coronary revascularization using totally endoscopic left internal mammary artery bypass grafting and placement of rapamycin eluting stents in the same interventional session: The COMBINATION pilot study. Cardiology 2007, 110:92-95.
34. Reicher B., Poston R.S., Mehra M.R., et al. Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: Feasibility, safety, and clinical outcomes. Am Heart J 2008, 155:661-667.
35. Zhao D.X., Leacche M., Balaguer J.M., et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol 2009, 53:232-241.
36. Holzhey D.M., Jacobs S., Mochalski M., et al. Minimally invasive hybrid coronary artery revascularization. Ann Thorac Surg 2008, 86:1856-1860.
37. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003, 349:1315-1323.
38. Hannan E.L., Wu C., Walford G., et al. Incomplete revascularization in the era of drug-eluting stents: Impact on adverse outcomes. JACC Cardiovasc Interv 2009, 2:17-25.
39. Vicol C., Raab S., Beyer M., et al. Myocardial revascularization using the arterial T graft: Which conduit should be chosen for the free graft?. Heart Surg Forum 2003, 6:353-357.
40. Byrne J.G., Leacche M., Vaughan D.E., et al. Hybrid cardiovascular procedures. JACC Cardiovasc Interv 2008, 1:459-468.
41. Umakanthan R., Leacche M., Petracek M.R., et al. Combined PCI and minimally invasive heart valve surgery for high risk patients. Curr Treat Options Cardiovasc Med 2009, 11:492-498.
42. Byrne J.G., Leacche M., Unic D., et al. Staged initial percutaneous coronary intervention followed by valve surgery ("hybrid approach") for patients with complex coronary and valve disease. J Am Coll Cardiol 2005, 45:14-18.
43. Brinster D.R., Byrne M., Rogers C.D., et al. Effectiveness of same day percutaneous coronary intervention followed by minimally invasive aortic valve replacement for aortic stenosis and moderate coronary disease ("hybrid approach"). Am J Cardiol 2006, 98:1501-1503.
44. Leacche M., Umakanthan R., Zhao D.X., et al. Surgical update: Hybrid procedures, do they have a role?. Circ Cardiovasc Interv 2010, 3:511-518.
45. Bisleri G., Curnis A., Bottio T., et al. The need of a hybrid approach for the treatment of atrial fibrillation. Heart Surg Forum 2005, 8:E326-E330.